Elligo Health Research的动态

By understanding more about a medication’s use in the real world, away from clinical settings, pharma companies and care providers have an opportunity to improve care, make it more personalised and patient centric and reduce health inequalities. In this paper, we explore the role of real-world patient data in improving health outcomes. Download now to understand the transformative power of patient reported data.?https://lnkd.in/eiQDwMRt #patientreporteddata #realworldevidence #patientinsights #pharma

Healthline Media insights on the patient experience were recently featured in EMARKETER! ?? EMARKETER highlights our survey results to show how patients with health conditions are interested in learning more about their treatment options and how pharma can better position themselves as patient educators. Interested in these insights? We shared more perspective on this data in last months The DHC Group report here: https://lnkd.in/ekE5gzaM #HealthlineMedia #digitalhealth #healthinformation #pharma

Developing treatments for #rarediseases comes with unique challenges. Limited patient populations make #clinicaltrials more difficult, while market access remains restricted due to the high research and development costs. Stringent regulatory pathways add complexity to bringing new therapies to market. Despite these hurdles, #innovation and collaboration are key to delivering life-saving treatments. If you want to learn more about how Medmonk is leveraging #technology and innovation to improve access to life-saving medication, visit our website at https://medmonk.com/ ?#rarediseases #pharmainnovation #patientaccess #copaytechnologies

Scientific advancements are happening at an unprecedented pace, with new discoveries and technologies emerging daily. Cures for previously untreatable diseases may soon become a reality. However, the process of making these innovations accessible to patients can be lengthy, costly, and complex. Moreover, the aging population, coupled with the widespread availability of information online, has made today's patients more informed and demanding than ever before. As a result, both chronic and rare diseases are being diagnosed more frequently, putting increased pressure on healthcare resources. Meanwhile, government payers face the challenge of balancing rising healthcare costs with the burden of record public debt. Healthcare companies, whether well-established, emerging, or yet to be founded, all face a similar challenge: navigating this uncertain landscape. How can they identify trustworthy partners to guide them through these complexities? Who will provide them with honest advice, and how many will encounter unnecessary failures along the way? What’s needed is a robust support system that offers a broader range of practical and independent advice throughout the entire commercialisation journey. A system where every project benefits from the expertise of professionals with real-life experience, ensuring that every recommendation is carefully vetted. This mechanism, free from vested interests, would provide truly independent guidance, enabling companies to make better decisions for the future of their patients. Healthcare companies deserve recognition for their groundbreaking discoveries and the hope they bring to patients’ lives. Contact us for more information [email protected] #healthcare #healthcareconsulting #patients #science #pharmaceutical #medicaldevices #biotech Vanessa Meikle Kate Webb Nicholette (Nicky) Conway James Jones Martin Hayes Daniel Thurley

Recently, pharma leaders shared their key learnings for achieving optimized #patientengagement and effectively integrating #patientinsights into #drugdevelopment and health outcomes. Click https://lnkd.in/enPp3_bV to watch the full video on the Reuters Events Pharma YouTube channel. A fraction of the many highlights can be found below. A huge thanks to Keri Yale, Ana Marija Gjurovic, MD, Beth Brooks, MPH, LSSBB, Bonnie Pobiner and Marko Mitrovic for a great discussion!

Take Your Practice to New Heights ?? : Discover the Latest in #Pharmacotherapy! Delve into groundbreaking developments in drug innovation, progressive therapies, and leading-edge research that is molding the pharmacotherapy field. Acquire valuable insights into critical updates on disease states, emerging trends, and pressing issues directly influencing your practice. Seize the chance to engage in this transformative pharmacotherapy experience. Secure your spot today and become a trailblazer in the future of healthcare! https://bit.ly/48hyKTG

???????? ?????????????????????? 2.0: ???? ???????????? ???????? ?????? ?????????????? What if the key to developing better treatments wasn't just hidden in labs but in the voices of patients themselves? That's the powerful message from a recent research paper that is reshaping how we think about drug development. It highlights the importance of incorporating patient perspectives early on, from understanding their needs and experiences to collaborating with them throughout the research process. This shift toward patient-centricity can lead to: - More effective treatments - Improved patient outcomes - A more human-centered healthcare system In my latest Substack article, you can learn more about this approach and explore the four key pillars of patient-centricity based on the paper. ?? https://lnkd.in/e4gdhtVc ?? doi: 10.1177/2168479017716492

New article alert! ?? Our latest blog post explores the exciting intersection of personalized medicine, big data, and virtual advisory boards. Discover how these innovations are transforming healthcare by tailoring treatments to individual patients. https://lnkd.in/g4N_US6e #personalizedmedicine #healthcareinnovation #bigdata #virtualadvisoryboards #pharma

A new study demonstrated that Extended-release buprenorphine (XR-Bup) was associated with a reduction in ED use six months after initiation, indicating a potential increase in patient adherence and a reduction in healthcare system costs overall (https://lnkd.in/e5XpSMnZ). Incremental or sustaining drug innovations like XR-Bup can disrupt the market and create enormous value for stakeholders. Ideas don't always have to be disruptive to create impact. Whether you have an idea for an incremental or a disruptive innovation, our program can help you identify how to move it into the market. Apply today - https://lnkd.in/e9FiW56p

Explore the rapidly expanding field of Medtech, a thriving industry that plays a crucial role in shaping our economy, enhancing healthcare, and driving innovation. Gain valuable insights by downloading our latest report today.